Management of Vitamin D Deficiency in Dialysis Patients

Introduction to Vitamin D Management

The American Journal of Kidney Diseases recommends adding ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) supplementation at 50,000 IU weekly for 8 weeks to correct nutritional vitamin D deficiency, while continuing the current calcitriol regimen unchanged, for patients with severe vitamin D insufficiency (level 13.6 ng/mL) 1, 2, 3
The National Kidney Foundation's K/DOQI guidelines provide the strongest evidence base for managing both nutritional vitamin D deficiency and calcitriol therapy in dialysis patients, stating that 25-hydroxyvitamin D levels below 30 ng/mL require ergocalciferol supplementation as a separate intervention from active vitamin D sterol therapy 1, 4

Ergocalciferol 50,000 IU orally once weekly for 8 weeks is recommended for the loading phase to rapidly replenish stores, with an alternative being cholecalciferol (vitamin D3) for better bioavailability and longer duration of action 1, 3
The maintenance phase involves continuing with 800-2,000 IU daily of cholecalciferol, targeting a serum 25-hydroxyvitamin D level of 30-80 ng/mL 3

Before initiating ergocalciferol, verify serum corrected calcium <10.2 mg/dL and serum phosphorus <4.6 mg/dL, and hold ergocalciferol if either parameter is elevated 1, 2
The current calcitriol dose (0.5 µg three times weekly) should remain unchanged unless PTH, calcium, or phosphorus levels are abnormal, and calcitriol addresses the hormonal deficiency related to impaired renal conversion of 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D 2, 4
Monthly PTH monitoring (every 3 months once stable) is recommended as per current calcitriol management, with a focus on preventing hypercalcemia and hyperphosphatemia 1, 2, 4

Calcitriol cannot correct nutritional vitamin D deficiency because it does not raise 25-hydroxyvitamin D levels, and dialysis patients need combination therapy with both nutritional vitamin D and calcitriol analogs 2
Stopping calcitriol when adding ergocalciferol is not recommended, as these medications serve different purposes and should be continued together, with ergocalciferol addressing the substrate deficiency and calcitriol addressing the hormonal deficiency 1, 2, 4